170 related articles for article (PubMed ID: 18269644)
21. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation.
Panjehpour M; Overholt BF; Haydek JM; Lee SG
Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
Ishihara R; Goda K; Oyama T
J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus.
Tokar JL; Haluszka O; Weinberg DS
Semin Radiat Oncol; 2007 Jan; 17(1):10-21. PubMed ID: 17185193
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic resection with or without mucosal ablation of high grade dysplasia and early oesophageal adenocarcinoma--long term follow up from a regional UK centre.
Oliphant Z; Snow A; Knight H; Barr H; Almond LM
Int J Surg; 2014 Nov; 12(11):1148-50. PubMed ID: 25234253
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Weusten BLAM; Bisschops R; Dinis-Ribeiro M; di Pietro M; Pech O; Spaander MCW; Baldaque-Silva F; Barret M; Coron E; Fernández-Esparrach G; Fitzgerald RC; Jansen M; Jovani M; Marques-de-Sa I; Rattan A; Tan WK; Verheij EPD; Zellenrath PA; Triantafyllou K; Pouw RE
Endoscopy; 2023 Dec; 55(12):1124-1146. PubMed ID: 37813356
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
[TBL] [Abstract][Full Text] [Related]
30. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
31. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
32. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Weston AP; Sharma P
Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
[TBL] [Abstract][Full Text] [Related]
33. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia.
Kohoutova D; Haidry R; Banks M; Bown S; Sehgal V; Butt MA; Graham D; Thorpe S; Novelli M; Rodriguez-Justo M; Lovat L
Scand J Gastroenterol; 2015; 50(11):1315-21. PubMed ID: 25956748
[TBL] [Abstract][Full Text] [Related]
34. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
[TBL] [Abstract][Full Text] [Related]
35. Comparison of endoscopic treatment modalities for Barrett's neoplasia.
David WJ; Qumseya BJ; Qumsiyeh Y; Heckman MG; Diehl NN; Wallace MB; Raimondo M; Woodward TA; Wolfsen HC
Gastrointest Endosc; 2015 Nov; 82(5):793-803.e3. PubMed ID: 26071064
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
38. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
[TBL] [Abstract][Full Text] [Related]
39. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
40. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
